新闻稿

Illumina公司网络直播即将举行的投资者会议

SAN DIEGO, Feb. 3, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conferences:

  • SVB Leerink 2022 Global Healthcare Conference on February 17, 2022
    Fireside Chat at 9:00am Pacific Time (12:00pm Eastern Time)
  • Citi 2022 Healthcare Conference on February 24, 2022
    Fireside Chat at 9:30am Pacific Time (12:30pm Eastern Time)

The live webcasts can be accessed under the Investor Info section of the "company" tab at www.illumina.com. A replay will be posted on Illumina's website after the event and will be available for at least 30 days following.

About Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and connect with us on Twitter, Facebook, LinkedIn, Instagram, and YouTube.

Investors:
Salli Schwartz
+1.858.291.6421
ir@illumina.com

Media:
Dr. Karen Birmingham
+1.646.355.2111
kbirmingham@illumina.com

 

CisionView original content:https://www.prnewswire.com/news-releases/illumina-to-webcast-upcoming-investor-conferences-301475244.html

SOURCE Illumina, Inc.

Recent Articles

在全新MiSeq™ i100系列中实现可持续的测序
在全新MiSeq™ i100系列中实现可持续的测序
对所有血癌进行全基因组测序的案例越来越多
对所有血癌进行全基因组测序的案例越来越多
独立检测证明DRAGEN提供了更为全面的基因组信息
独立检测证明DRAGEN提供了更为全面的基因组信息